Osaic Holdings
ACTU

Osaic Holdings’s Actuate Therapeutics ACTU Stock Holding History

Osaic Holdings’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74K Hold
1,000
– – ﹤0.01% 6931
2025
Q4 		$6.12K Hold
1,000
– – ﹤0.01% 6588
2025
Q3 		$8.44K Hold
1,000
– – ﹤0.01% 6468
2025
Q2 		$6.11K Buy
+1,000
New +$8.74K ﹤0.01% 6429

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's ACTU Position: Q1 2026 in Review

Osaic Holdings held its Actuate Therapeutics (ACTU) position steady in Q1 2026 at 1,000 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #6931.

Osaic Holdings first reported a position in ACTU in Q2 2025 and has held it in 4 quarters since. The position peaked at $8.44K in Q3 2025. 61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Osaic Holdings held 1,000 shares of Actuate Therapeutics worth $2.74K as of Q1 2026.
  • Osaic Holdings left its Actuate Therapeutics share count unchanged in Q1 2026.
  • Actuate Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6931 holding.
  • Osaic Holdings first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Osaic Holdings's Actuate Therapeutics position peaked at $8.44K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.